Cardinal Health Extends Distribution Agreement with CVS Health until 2032

By Greg Peters • Thursday, October 01 10:48 • Permanent Link

Cardinal Health said it has signed a binding letter of intent to extend its pharmaceutical distribution agreement with CVS Health through June 30, 2032, keeping the current scope of distribution services in place.

The company also reaffirmed its fiscal 2027 non-GAAP EPS outlook at 13% to 15% growth, or $12.40 to $12.60 a share. That guidance implies a lift from adjusted fiscal 2026 results, which Cardinal said excluded the benefit of an IEEPA tariff refund.

Cardinal said it expects to provide additional updates on the deal and its financial outlook during its first-quarter earnings call on Nov. 5, 2026. Today the company's shares have moved -0.63% to a price of $222.50. For more information, read the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.